Advocacy intelligence hub — real-time data for patient organizations
DALFAMPRIDINE: New indication approved
DALFAMPRIDINE: New indication approved
DALFAMPRIDINE: FDA approved
Ampyra: FDA approved
Treatment to improve walking in patients with multiple sclerosis
Novantrone: FDA approved
Reducing neurologic disability and/or the frequency of clinical relapses in patients with secondary (chronic) progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis (i.e., patients whose neurologic status is significantly adnormal between relapses).
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance9
Mitoxantrone
EMD Serono
BACLOFEN
REMEDYREPACK INC.
Novantrone
Serono, Inc.
Betaseron
Bayer
AMPYRA
Acorda
Cladribine
EMD Serono
GLATIRAMER ACETATE
Teva
Copaxone
Teva
DALFAMPRIDINE
Acorda
Ampyra
(dalfampridine)Orphan drugAcorda Therapeutics
Potassium Channel Blocker [EPC]
12.1 Mechanism of action The mechanism by which dalfampridine exerts its therapeutic effect has not been fully elucidated. Dalfampridine is a broad sp...
Novantrone
(Mitoxantrone)Orphan drugSerono, Inc.
Mechanism of Action Mitoxantrone, a DNA-reactive agent that intercalates into deoxyribonucleic acid (DNA) through hydrogen bonding, causes crosslinks ...
Betaseron
(Interferon beta-1b)Orphan drugstandardChiron Corp. & Berlex Laboratories
12.1 Mechanism of Action The mechanism of action of BETASERON (interferon beta-1b) in patients with multiple sclerosis is unknown.
Copaxone
(glatiramer acetate)Orphan drugstandardTeva Pharmaceuticals USA
12.1 Mechanism of Action The mechanism(s) by which glatiramer acetate exerts its effects in patients with MS are not fully understood. However, glatir...
Avonex
(Interferon beta-1a)Orphan drugstandardBiogen, Inc.
Interferon beta [EPC]
12.1 Mechanism of Action The mechanism of action by which AVONEX exerts its effects in patients with multiple sclerosis is unknown.
View all NON RARE IN EUROPE: Multiple sclerosis specialists →